6-K 1 tm2213999d6_6k.htm FORM 6-K

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

 

UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of May 2022

 

Commission File Number: 001-37775 Commission file number 001-41313
   
Brookfield Business Partners L.P.
(Exact name of Registrant as specified in its charter)
BROOKFIELD BUSINESS CORPORATION
(Exact name of Registrant as specified in its charter)
   
73 Front Street, 5th Floor
Hamilton, HM 12 Bermuda
(Address of principal executive office)
250 Vesey Street, 15th Floor
New York, New York 10281
(Address of principal executive office)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F x Form 40-F ¨

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ¨

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ¨

 

The information in this Form 6-K is incorporated by reference into Brookfield Business Partners L.P.’s registration statements on F-3 (File Nos. 333-264630, 333-258765 and 333-251316).

 

 

 

 

 

 

DOCUMENTS FILED AS PART OF THIS FORM 6-K

 

See the Exhibit Index to this Form 6-K.

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  Brookfield Business Partners L.P.
  by its general partner, Brookfield Business Partners Limited
     
Date: May 10, 2022  By:  /s/ Jane Sheere    
    Name: Jane Sheere
    Title: Corporate Secretary
     
  BROOKFIELD BUSINESS CORPORATION
     
Date: May 10, 2022  By:  /s/ Jaspreet Dehl       
    Name: Jaspreet Dehl
    Title: Chief Financial Officer

 

 

 

 

EXHIBIT INDEX

 

 

EXHIBIT   DESCRIPTION
99.1   The unaudited consolidated financial statements of CDK Global Inc. as of March 31, 2022 and June 30, 2021 and for the three and nine months ended March 31, 2022 and 2021.